The Department of Health told a legislative committee that any use of opioid-settlement grant funds to purchase a building for an overdose prevention center would require additional administrative steps, including a facility service assessment and appropriate insurance documentation.
Dr. Hildebrandt, commissioner of the Department of Health, said the legislature instructed the agency to serve as grant administrator and not to act as decision-maker for subgrantee program choices. "When the appropriation was first made...we shouldn't be in a sort of decision making capacity in this...grant," the commissioner said, and added that purchasing a building “was never contemplated” during the original design of the grant, though the appropriation did not explicitly rule out that use.
The commissioner urged that the city of Burlington and the overdose-prevention center operator (referred to in the hearing as VCJR) discuss prospective facility purchases and ongoing operational funding with OSAC (the relevant grant advisory forum) and stressed that a service assessment — a review that verifies whether a facility is suited to the grant-supported service — had not been received from the subgrantee. The department also said that if funds were used to pay a mortgage or an operational share of a building, only the portion of space actually used for the overdose-prevention center should be covered by the grant.
Committee members asked whether Burlington or the subgrantee had a specific building under consideration and whether municipal development review/DRB processes and neighbor notification would apply; the commissioner said she did not have those details but advised that those are valid local considerations and that leasing had previously been difficult because of community opposition.
Members also raised practical questions about insurance for facilities and the timing of payments; the commissioner confirmed that insurance and the service assessment are among required items before the department could release further payments.
The committee agreed to invite representatives from Burlington and VCJR to testify at a later hearing and indicated it may move the bill forward on a parallel schedule while other committees or the senate address unresolved issues about the grant conditions and oversight.
Next steps: the committee will seek testimony from the city and the subgrantee, request the outstanding service assessment and insurance information, and will continue discussing appropriate guardrails for any capital or operational funding tied to the opioid-settlement appropriation.